» Articles » PMID: 6811434

Immunoglobulin M and G Antibody Responses and Persistence of These Antibodies in Adults After Vaccination with a Combined Meningococcal Group A and Group C Polysaccharide Vaccine

Overview
Journal Infect Immun
Date 1982 Aug 1
PMID 6811434
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Adult volunteers were injected with a combined meningococcal group A and group C polysaccharide vaccine. Immunoglobulin M (IgM) and IgG antibody levels against both polysaccharides were measured in serum samples taken 14 days as well as 3 years after vaccination. For both group A and group C polysaccharides, the IgM and IgG antibody levels at 14 days postvaccination were positively related. The IgM-to-IgG antibody ratio at 14 days postvaccination was an indicator for the persistence of both IgM and IgG antibodies during the next 3 years; a high ratio meant a short persistence, whereas a low ratio was associated with a long persistence.

Citing Articles

Herd Protection against Meningococcal Disease through Vaccination.

Clark S, Borrow R Microorganisms. 2020; 8(11).

PMID: 33126756 PMC: 7693901. DOI: 10.3390/microorganisms8111675.


Meningococcal vaccines. Current status and future possibilities.

Peltola H Drugs. 1998; 55(3):347-66.

PMID: 9530542 DOI: 10.2165/00003495-199855030-00003.


Comparison of radioimmunoassay and enzyme-linked immunosorbent assay in measurement of antibodies to Neisseria meningitidis group A capsular polysaccharide.

Beuvery E, Kayhty M, Leussink A, Kanhai V J Clin Microbiol. 1984; 20(4):672-6.

PMID: 6436314 PMC: 271408. DOI: 10.1128/jcm.20.4.672-676.1984.


Activation of murine B lymphocytes by Neisseria meningitidis and isolated meningococcal surface antigens.

Melancon J, Murgita R, DeVoe I Infect Immun. 1983; 42(2):471-9.

PMID: 6417015 PMC: 264453. DOI: 10.1128/iai.42.2.471-479.1983.


Immunological evaluation of meningococcal group C polysaccharide-tetanus toxoid conjugate in mice.

Beuvery E, Van Delft R, Miedema F, Kanhai V, Nagel J Infect Immun. 1983; 41(2):609-17.

PMID: 6409811 PMC: 264686. DOI: 10.1128/iai.41.2.609-617.1983.


References
1.
Braley-Mullen H . Secondary IgG responses to type 3 pneumococcal polysaccharide. III. T cell requirement for development of B memory cells. Eur J Immunol. 1977; 7(11):775-81. DOI: 10.1002/eji.1830071106. View

2.
Peltola H, Kayhty H, Sivonen A, Makela H . Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland. Pediatrics. 1977; 60(5):730-7. View

3.
Robbins J . Vaccines for the prevention of encapsulated bacterial diseases: current status, problems and prospects for the future. Immunochemistry. 1978; 15(10-11):839-54. DOI: 10.1016/0161-5890(78)90117-7. View

4.
Dresser D, Popham A . The influence of T cells on the initiation and expression of immunological memory. Immunology. 1979; 38(2):265-74. PMC: 1457934. View

5.
Schneerson R, Barrera O, Sutton A, Robbins J . Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates. J Exp Med. 1980; 152(2):361-76. PMC: 2185954. DOI: 10.1084/jem.152.2.361. View